• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Abdelreheem, A., Zeitoun, M., Elrahmany, S., Mohamud, A. (2022). STUDY OF SERUM VITAMIN B 12 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. ALEXMED ePosters, 4(4), 5-6. doi: 10.21608/alexpo.2022.167120.1475
Ali Ahmed Abdelreheem; Mohammed Zeitoun; Shimaa Mohamed Elrahmany; Abdirahim Sheikh Mohamud. "STUDY OF SERUM VITAMIN B 12 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS". ALEXMED ePosters, 4, 4, 2022, 5-6. doi: 10.21608/alexpo.2022.167120.1475
Abdelreheem, A., Zeitoun, M., Elrahmany, S., Mohamud, A. (2022). 'STUDY OF SERUM VITAMIN B 12 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS', ALEXMED ePosters, 4(4), pp. 5-6. doi: 10.21608/alexpo.2022.167120.1475
Abdelreheem, A., Zeitoun, M., Elrahmany, S., Mohamud, A. STUDY OF SERUM VITAMIN B 12 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. ALEXMED ePosters, 2022; 4(4): 5-6. doi: 10.21608/alexpo.2022.167120.1475

STUDY OF SERUM VITAMIN B 12 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Article 3, Volume 4, Issue 4, December 2022, Page 5-6  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.167120.1475
View on SCiNiTO View on SCiNiTO
Authors
Ali Ahmed Abdelreheem1; Mohammed Zeitoun2; Shimaa Mohamed Elrahmany1; Abdirahim Sheikh Mohamud email 1
1Department of Internal Medicine, Faculty of Medicine, Alexandria University
2department of internal medicine, faculty of medicine, Alexandria university, Egypy
Abstract
Nearly 90% of all cases of diabetes mellitus (DM) are of type 2 diabetes (T2DM), which is the most prevalent type. Hyperglycemia, which commonly results from insufficient insulin production on the backdrop of insulin resistance, is a hallmark of T2DM.
Alterations in cellular homeostasis brought on by persistent hyperglycemia in diabetes mellitus (DM) result in diffuse vascular damage and the emergence of long-term micro- and macrovascular complications. Damage to small blood arteries causes microvascular complications, such as diabetic neuropathy (DN), diabetic retinopathy, and diabetic kidney disease (DKD).
Over the years, metformin has been regarded as the best and initial therapeutic option for the management of type 2 diabetes. Vitamin B12 deficiency is one of the known potential adverse effects of long-term metformin use.
AIM OF THE WORK:
The aim of the study was to:
1. Assess the levels of serum vitamin B12 in patients with type 2 diabetes.
2. Study the relation between serum vitamin B12 and metformin usage index in patients with type 2 diabetes.
3. Study the relation between serum vitamin B12 and peripheral neuropathy in patients with type 2 diabetes.
4. Study therelation of vitamin B12 supplementations intake with serum vitamin B12 and peripheral neuropathy in patients with type 2 diabetes on metformin.
Keywords
TYPE 2 DIABETES MELLITUS; metformin; VITAMIN B 12
Supplementary Files
download 1475 11.pdf
Statistics
Article View: 128
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.